ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23 | -85.9% | 2,073 | -72.9% | 0.00% | -100.0% |
Q2 2023 | $163 | -51.3% | 7,638 | -7.8% | 0.00% | -66.7% |
Q1 2023 | $335 | -18.9% | 8,284 | -6.7% | 0.00% | -25.0% |
Q4 2022 | $413 | -99.9% | 8,881 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $461,000 | +15.0% | 8,881 | +4.7% | 0.00% | 0.0% |
Q2 2022 | $401,000 | -32.9% | 8,482 | +1.0% | 0.00% | -20.0% |
Q1 2022 | $598,000 | -54.3% | 8,396 | -52.0% | 0.01% | 0.0% |
Q4 2021 | $1,308,000 | +155.5% | 17,496 | +94.3% | 0.01% | +25.0% |
Q3 2021 | $512,000 | +27.0% | 9,004 | -1.6% | 0.00% | +33.3% |
Q2 2021 | $403,000 | +94.7% | 9,153 | +173.4% | 0.00% | -25.0% |
Q4 2019 | $207,000 | -23.9% | 3,348 | +3.7% | 0.00% | -33.3% |
Q2 2019 | $272,000 | +4.2% | 3,228 | +18.0% | 0.01% | 0.0% |
Q1 2019 | $261,000 | -17.1% | 2,736 | +0.8% | 0.01% | -25.0% |
Q2 2018 | $315,000 | – | 2,714 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |